Clinical Trial: TAIZ -Monocytes for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (Cadaver Kidney)

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: A Single-Center Open-Labelled Study of the Administration of Transplant-Acceptance Inducing Cells (TAIZ) for the Induction of Donor Specific Tolerance in Renal Allograft Recipients (

  • graft survival
  • replacement of immunosuppressives after treatment with Transplant-Acceptance Inducing Cells (TAIC)
  • serum creatinine
  • rejection episodes
  • re-introduction of immunosuppressives.


    • Original Primary Outcome: Same as current

    Current Secondary Outcome: safety and tolerability of the treatment with Transplant-Acceptance Inducing Cells (TAIC) Adverse Events (AEs)

    Original Secondary Outcome: Same as current

    Information By: University of Schleswig-Holstein

    Dates:
    Date Received: September 14, 2005
    Date Started: February 2004
    Date Completion: August 2005
    Last Updated: October 27, 2005
    Last Verified: April 2003